Roche said this week that Erich Hunziker, current chief financial officer, chief information officer, and deputy head of the corporate executive committee, will retire at the end of March to focus on a number of board memberships.
Hunziker was appointed CFO in 2001, and became deputy head of the corporate executive committee in 2005. In 2010, he assumed the role of CIO.
Roche also said that it has appointed Alan Hippe to succeed Hunziker as CFO. Hippe will join Roche in April as a member of the corporate executive committee. Hippe served as a member of the executive board of Continental AG from 2002 to 2009. Since April 2009, he has been CFO and board member of ThyssenKrupp.
WaferGen Biosystems said this week that it has appointed Arul Chinnaiyan to its scientific advisory board.
Chinnaiyan is a professor of pathology and urology at the University of Michigan and director of the Michigan Center for Translational Pathology. He co-founded Compendia Bioscience in February 2006, after his laboratory developed the Oncomine cancer profiling bioinformatics resource. Chinnaiyan is also an investigator at the Howard Hughes Medical Institute; is a member of the Institute of Medicine of the National Academies of Science; and serves on the National Cancer Institute's scientific advisory board. He holds an MD and PhD from the University of Michigan.
In a statement, WaferGen Chairman and CEO Alnoor Shivji said that Chinnaiyan's expertise in the use of biomarkers to choose appropriate therapies for cancer patients will be "invaluable to support WaferGen's development of impactful products for genomics analysis including current product selection as well as future molecular diagnostics programs."